Skip to main content
Caplight Logo









P1vital

P1vital

Private
WallingfordHealthcare & Life Scienceshttps://p1vital.com

Last Round

M&A

Jul 13, 2022

Company Overview

P1vital operates in Healthcare & Life Sciences and is based in Wallingford. Its latest recorded funding round was a Grant round in April 2019.

P1vital is a biotechnology and digital health company that provides neuroscience research, clinical trial services, and computerized behavioral testing tools for psychiatric and CNS disorders.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Mental Health, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

P1vital Comparables

Compare P1vital with similar companies based on industry and business-model similarity.

P1vital comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cambridge Cognition Holdings Plc
78%
Cogstate
77%
Clinilabs
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

P1vital Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AJul 13, 2022
GrantApr 1, 2019
VC RoundOct 24, 2018
VC RoundJul 26, 2016
VC RoundJan 29, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

P1vital Investors

Notable investors and investment history

P1vital investors
InvestorRounds
Boehringer IngelheimGrant
Mercia Asset ManagementVC Round
Catapult VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Grew 17% QoQ, from 18 to 21 employees.

  • Jul 13, 2022

    Completed an M&A round.

Book a demo to see all signals

For institutional investors. Book with your work email.

P1vital Filings

Explore SEC and related filing metadata, where available.

P1vital filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about P1vital's valuation, stock price, and market status.

Is P1vital a public or private company?

P1vital is a private company.

What is the current stock price of P1vital?

P1vital is a private company, so its shares have no public market price. Caplight tracks P1vital's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is P1vital worth (valuation)?

Valuation information for P1vital is not publicly available.

Can I buy P1vital stock?

P1vital shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was P1vital's last funding round?

P1vital's most recent funding round was M&A on July 13, 2022.

Who are the main investors in P1vital?

Key investors in P1vital include Mercia Asset Management.

Will P1vital IPO soon?

No public IPO plans have been announced for P1vital.

How can I track P1vital secondary market activity?

Caplight tracks bids, offers, and trades in P1vital's shares on secondary markets.

Firmographic Details

HeadquartersWallingford
Employee Range15
Year Founded2004
Last FundingJul 13, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?